Antibody engineering enables the generation of novel and diverse antibody constructs. The development of therapeutic antibodies is highly dependent on antibody engineering, whether for the generation ...

Antibody engineering is moving into its fourth decade, a stage of maturity that emphasizes both the success and the challenges of the discipline. One problem that antibody-engineering companies have ...

Since December 2023, RevolKa has offered contract research services for antibody engineering using aiProtein ®, its AI-driven protein engineering technology, through FUJIFILM Wako Pure Chemical ...

Trends in Synthetic Biology: Antibody Engineering from thescientistllc on Vimeo. As the body’s circulating army of first responders, antibodies recognize and destroy foreign and potentially ...

In April, the FDA announced an ambitious plan to phase out animal testing requirements for monoclonal antibodies and other therapies in an effort to improve drug safety and reduce R&D costs. The goal ...

New analysis from the Antibody Collaboration and Licensing Deals report shows pharma committing record capital to differentiated antibody assets and the technologies that generate them.Dublin, June 11 ...

Therapeutic antibody optimization is a long and iterative process. AI can help increase scale and throughput, but accelerating antibody discovery and optimization timelines requires massive ...

R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins. It’s the first part of what the company describes will grow to become a ...

Researchers have engineered CAR-T cells armed with computationally designed protein binders that eliminated glioblastoma ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...